ロート製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/09/06 | 3,556 | 3,631 | 3,556 | 3,630 | +80 | +2.3% | 614,300 |
2024/09/05 | 3,600 | 3,621 | 3,527 | 3,550 | -20 | -0.6% | 546,900 |
2024/09/04 | 3,586 | 3,630 | 3,533 | 3,570 | -71 | -2% | 829,500 |
2024/09/03 | 3,476 | 3,641 | 3,461 | 3,641 | +196 | +5.7% | 1,084,700 |
2024/09/02 | 3,452 | 3,476 | 3,408 | 3,445 | -31 | -0.9% | 437,900 |
2024/08/30 | 3,452 | 3,477 | 3,443 | 3,476 | +25 | +0.7% | 600,200 |
2024/08/29 | 3,439 | 3,478 | 3,432 | 3,451 | -20 | -0.6% | 428,200 |
2024/08/28 | 3,500 | 3,521 | 3,412 | 3,471 | +4 | +0.1% | 981,700 |
2024/08/27 | 3,356 | 3,474 | 3,322 | 3,467 | +145 | +4.4% | 633,100 |
2024/08/26 | 3,300 | 3,330 | 3,293 | 3,322 | +8 | +0.2% | 360,300 |
2024/08/23 | 3,330 | 3,342 | 3,305 | 3,314 | -11 | -0.3% | 417,800 |
2024/08/22 | 3,216 | 3,329 | 3,215 | 3,325 | +140 | +4.4% | 849,700 |
2024/08/21 | 3,180 | 3,208 | 3,170 | 3,185 | -6 | -0.2% | 516,300 |
2024/08/20 | 3,199 | 3,277 | 3,183 | 3,191 | +12 | +0.4% | 570,000 |
2024/08/19 | 3,251 | 3,252 | 3,159 | 3,179 | -61 | -1.9% | 511,500 |
2024/08/16 | 3,248 | 3,260 | 3,185 | 3,240 | +14 | +0.4% | 578,700 |
2024/08/15 | 3,233 | 3,243 | 3,172 | 3,226 | +4 | +0.1% | 789,300 |
2024/08/14 | 3,277 | 3,280 | 3,177 | 3,222 | -24 | -0.7% | 476,000 |
2024/08/13 | 3,275 | 3,290 | 3,199 | 3,246 | +58 | +1.8% | 588,100 |
2024/08/09 | 3,423 | 3,437 | 3,131 | 3,188 | -190 | -5.6% | 1,447,200 |
2024/08/08 | 3,254 | 3,395 | 3,161 | 3,378 | +61 | +1.8% | 1,735,500 |
2024/08/07 | 3,233 | 3,380 | 3,225 | 3,317 | +84 | +2.6% | 784,800 |
2024/08/06 | 3,164 | 3,255 | 3,119 | 3,233 | +246 | +8.2% | 957,900 |
2024/08/05 | 3,096 | 3,184 | 2,935 | 2,987 | -261 | -8% | 872,500 |
2024/08/02 | 3,338 | 3,359 | 3,243 | 3,248 | -148 | -4.4% | 741,900 |
2024/08/01 | 3,487 | 3,487 | 3,360 | 3,396 | -139 | -3.9% | 805,900 |
2024/07/31 | 3,450 | 3,541 | 3,448 | 3,535 | +36 | +1% | 568,900 |
2024/07/30 | 3,517 | 3,517 | 3,476 | 3,499 | -36 | -1% | 463,100 |
2024/07/29 | 3,445 | 3,540 | 3,445 | 3,535 | +84 | +2.4% | 394,600 |
2024/07/26 | 3,459 | 3,497 | 3,444 | 3,451 | -21 | -0.6% | 485,300 |
2024/07/25 | 3,461 | 3,513 | 3,433 | 3,472 | -18 | -0.5% | 581,300 |
2024/07/24 | 3,480 | 3,512 | 3,459 | 3,490 | -5 | -0.1% | 462,200 |
2024/07/23 | 3,464 | 3,543 | 3,448 | 3,495 | -9 | -0.3% | 574,500 |
2024/07/22 | 3,500 | 3,528 | 3,472 | 3,504 | +33 | +1% | 686,600 |
2024/07/19 | 3,465 | 3,488 | 3,451 | 3,471 | -36 | -1% | 511,300 |
2024/07/18 | 3,454 | 3,547 | 3,454 | 3,507 | +47 | +1.4% | 949,800 |
2024/07/17 | 3,404 | 3,474 | 3,391 | 3,460 | +78 | +2.3% | 722,900 |
2024/07/16 | 3,480 | 3,500 | 3,382 | 3,382 | -76 | -2.2% | 871,200 |
2024/07/12 | 3,411 | 3,477 | 3,391 | 3,458 | +43 | +1.3% | 789,200 |
2024/07/11 | 3,400 | 3,433 | 3,384 | 3,415 | +46 | +1.4% | 763,800 |
2024/07/10 | 3,357 | 3,395 | 3,355 | 3,369 | +35 | +1% | 657,800 |
2024/07/09 | 3,327 | 3,353 | 3,301 | 3,334 | +18 | +0.5% | 551,300 |
2024/07/08 | 3,251 | 3,316 | 3,251 | 3,316 | +52 | +1.6% | 886,600 |
2024/07/05 | 3,245 | 3,289 | 3,241 | 3,264 | +19 | +0.6% | 733,200 |
2024/07/04 | 3,234 | 3,269 | 3,221 | 3,245 | -35 | -1.1% | 854,800 |
2024/07/03 | 3,253 | 3,292 | 3,232 | 3,280 | -8 | -0.2% | 1,113,000 |
2024/07/02 | 3,321 | 3,340 | 3,287 | 3,288 | -60 | -1.8% | 933,100 |
2024/07/01 | 3,375 | 3,386 | 3,325 | 3,348 | -23 | -0.7% | 786,100 |
2024/06/28 | 3,346 | 3,385 | 3,335 | 3,371 | +47 | +1.4% | 850,900 |
2024/06/27 | 3,330 | 3,357 | 3,303 | 3,324 | -10 | -0.3% | 523,100 |
51~
100
件表示中 / 3585件
類似銘柄と比較する
現在ご覧いただいている「ロート」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ロート | 274,500円 | +18.2% | +4.2% | 1.20% | 19.45倍 | 2.48倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
協和キリン | 254,500円 | +11.3% | -5.4% | 2.28% | 19.59倍 | 1.54倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
小野薬 | 174,600円 | -3.5% | -50.2% | 4.58% | 14.14倍 | 1.05倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
参天薬 | 166,400円 | 0.0% | +50.6% | 2.04% | 17.73倍 | 1.99倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
ツムラ | 482,300円 | +22.6% | +68.1% | 2.82% | 12.85倍 | 1.24倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
市場注目の銘柄
チャート関連のコラム